Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127290191 | 12729019 | 1 | I | 20160901 | 20160909 | 20160909 | EXP | JP-SA-2016SA164578 | AVENTIS | 0.00 | A | F | Y | 0.00000 | 20160909 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127290191 | 12729019 | 1 | PS | MYSLEE | ZOLPIDEM TARTRATE | 1 | Oral | UNKNOWN | 19908 | 5 | MG | FILM-COATED TABLET | QD | ||||||
| 127290191 | 12729019 | 2 | C | NEUROTROPIN | NEUROTROPIN | 1 | Oral | 0 | |||||||||||
| 127290191 | 12729019 | 3 | C | METHYCOBAL | METHYLCOBALAMIN | 1 | Oral | 0 | |||||||||||
| 127290191 | 12729019 | 4 | C | CINAL | ASCORBIC ACIDCALCIUM PANTOTHENATE | 1 | Oral | 0 | |||||||||||
| 127290191 | 12729019 | 5 | C | JUVELA | .ALPHA.-TOCOPHEROLRETINOL | 1 | Oral | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127290191 | 12729019 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127290191 | 12729019 | Cataract |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |